Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ExtendicareEXETF -1.93%61 10-Year Share Buyback Ratio is 0.10 as of Jun. 2026. GuruFocus rates EXETF with a GF Score™ of 61/100 and a GF Value™ of $11.43 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 300 Healthcare Providers & Services companies, Extendicare ranks better than 86% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Extendicare's current 10-Year Share Buyback Ratio was 0.10%.
EXETF's 10-Year Share Buyback Ratio is ranked better than 86% of 300
companies
in the Healthcare Providers & Services industry
Industry Median: -2
vs EXETF: 0.10
Extendicare (OTCPK:EXETF) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Extendicare 10-Year Share Buyback Ratio Related Terms
EXETF vs HCA, THC, DVA: 10-Year Share Buyback Ratio Comparison
For the Medical Care Facilities subindustry, Extendicare's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare 10-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Extendicare's 10-Year Share Buyback Ratio falls into.
Extendicare 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of 0.10 mean?
Extendicare (EXETF) has a 10-Year Share Buyback Ratio of 0.10 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Extendicare and its competitors. According to the industry distribution chart, Extendicare ranks #42 out of 300 companies in the Healthcare Providers & Services industry, placing it in the top 14%.
Is Extendicare's 10-Year Share Buyback Ratio too high?
Extendicare's current 10-Year Share Buyback Ratio is 0.10. Based on the distribution chart, Extendicare ranks #42 out of 300 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Extendicare has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's 10-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #42 out of 300 companies for 10-Year Share Buyback Ratio. This places Extendicare in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 10-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Extendicare and its competitors. Extendicare's current 10-Year Share Buyback Ratio is 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.43, compared to a current price of $22.81 — trading 99.6% above its estimated fair value. The current 10-Year Share Buyback Ratio is 0.10. Extendicare's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Extendicare (EXETF), the current 10-Year Share Buyback Ratio is 0.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $22.81 is trading 99.6% above its estimated GF Value™ of $11.43.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
10-Year Share Buyback Ratio: 0.10
GF Value™: $11.43 vs. price of $22.81 (99.6% above fair value)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
61GF Score
Get the complete analysis for EXETF
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 
